Cite
HARVARD Citation
Adams, D. et al. (2014). Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP). Orphanet journal of rare diseases. 9 (1), pp. 1-2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Adams, D. et al. (2014). Phase 2 open-label extention (OLE) study of patisiran, an investigational siRNA agent for familial amyloidotic polyneuropathy (FAP). Orphanet journal of rare diseases. 9 (1), pp. 1-2. [Online].